(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Annual Meeting’s included a session on biomarkers and salvage radiotherapy and discussion by Dr. Paul Nguyen regarding the validation of a 22-gene genomic classifier in the NRG Oncology/RTOG 9202, 9413, and 9902 phase III randomized trials.